2,327
Views
3
CrossRef citations to date
0
Altmetric
Articles/Brief Reports

Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis

, , , , , , , , & show all
Pages 135-141 | Accepted 03 May 2021, Published online: 02 Sep 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.